Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : TCRT-ESO-A2
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : PharmaEssentia
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Axis Therapeutics and PharmaEssentia will collaborate to conduct an initial clinical study of Axis Therapeutics’ TCRT-ESO-A2 therapy, targeting solid tumors that are NY-ESO-1 positive in HLA-A positive patients, and to manufacture the investigational p...
Product Name : TCRT-ESO-A2
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
October 13, 2020
Lead Product(s) : TCRT-ESO-A2
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : PharmaEssentia
Deal Size : Undisclosed
Deal Type : Collaboration